Stockscreener 앱 받기
27.80
15.02%
3.63
시간 외 거래:
27.69
-0.11
-0.40%
전일 마감가:
$24.17
열려 있는:
$24.13
하루 거래량:
3.75M
Relative Volume:
2.37
시가총액:
$1.57B
수익:
$249.12M
순이익/손실:
$-90.19M
주가수익비율:
-16.35
EPS:
-1.7
순현금흐름:
$-88.21M
1주 성능:
+4.67%
1개월 성능:
-2.46%
6개월 성능:
-28.05%
1년 성능:
-53.33%
1일 변동 폭
$23.71
$27.87
1주일 범위
$22.77
$27.87
52주 변동 폭
$19.35
$66.85
Procept Biorobotics Corp Stock (PRCT) Company Profile
명칭
Procept Biorobotics Corp
전화
(650) 232-9832
주소
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
27.80 | 1.36B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
110.25 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
345.78 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
88.97 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.63 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.09 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-06 | 개시 | Robert W. Baird | Neutral |
| 2026-02-26 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2026-02-26 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-12-12 | 개시 | UBS | Buy |
| 2025-12-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-09-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-07-09 | 개시 | Stephens | Overweight |
| 2025-07-07 | 개시 | Oppenheimer | Perform |
| 2024-12-02 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 개시 | Jefferies | Hold |
| 2023-08-11 | 개시 | Piper Sandler | Overweight |
| 2023-05-31 | 개시 | William Blair | Outperform |
| 2022-10-31 | 개시 | BTIG Research | Neutral |
| 2022-10-25 | 개시 | Truist | Buy |
| 2022-09-02 | 개시 | Wells Fargo | Overweight |
| 2022-07-15 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2021-10-11 | 개시 | BofA Securities | Buy |
| 2021-10-11 | 개시 | Cowen | Outperform |
| 2021-10-11 | 개시 | Goldman | Neutral |
| 2021-10-11 | 개시 | Guggenheim | Buy |
| 2021-10-11 | 개시 | SVB Leerink | Outperform |
모두보기
Procept Biorobotics Corp 주식(PRCT)의 최신 뉴스
PROCEPT BioRobotics Corporation (PRCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - The AI Journal
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - Benzinga
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap Up on Insider Buying Activity - MarketBeat
Is PROCEPT’s Growth Targets And New CFO Director Altering The Investment Case For PROCEPT BioRobotics (PRCT)? - simplywall.st
Major Insider Shake-Up at PROCEPT BioRobotics as Top Executives Trade Shares - TipRanks
Procept Biorobotics director Desai buys PRCT shares worth $10.4m - Investing.com Nigeria
Procept Biorobotics director Desai buys PRCT shares worth $10.4m By Investing.com - Investing.com Australia
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The AI Journal
PROCEPT BioRobotics (NASDAQ:PRCT) Director Antal Rohit Desai Purchases 167,246 Shares - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Director Buys $3,781,878.03 in Stock - MarketBeat
Insider Buying: PROCEPT BioRobotics (NASDAQ:PRCT) Director Acquires 98,699 Shares of Stock - MarketBeat
Kevin Waters Sells 6,721 Shares of PROCEPT BioRobotics (NASDAQ:PRCT) Stock - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) EVP Sells $163,340.40 in Stock - MarketBeat
Alaleh Nouri, EVP at Procept Biorobotics, sells $163k in shares - Investing.com India
PRCT Investors Have Opportunity to Join PROCEPT BioRobotics Corporation Fraud Investigation with the Schall Law Firm - Business Wire
PROCEPT BioRobotics Corporation $PRCT Shares Purchased by Rhenman & Partners Asset Management AB - MarketBeat
Blair William & Co. IL Purchases 169,237 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics Adds Independent Director to Audit Committee - The Globe and Mail
Baird Initiates Coverage of PROCEPT BioRobotics (PRCT) with Neutral Recommendation - Nasdaq
Baird initiates Procept BioRobotics stock rating at Neutral By Investing.com - Investing.com India
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Down 6.9%Time to Sell? - MarketBeat
Baird initiates Procept BioRobotics stock rating at Neutral - Investing.com
Robert W. Baird Initiates Coverage on PROCEPT BioRobotics (NASDAQ:PRCT) - MarketBeat
Procept Biorobotics Corporation Appoints Daniel Puckett Board and Audit Committee Member, Effective March 5, 2026 - marketscreener.com
PRCT: Baird Initiates Neutral Rating with $30 Price Target | PRC - GuruFocus
Procept BioRobotics appoints Daniel Puckett to board and audit committee - Investing.com
Procept BioRobotics initiated with a Neutral at Baird - TipRanks
A Look At PROCEPT BioRobotics (PRCT) Valuation After Earnings Miss And New 2026 To 2027 Guidance - simplywall.st
PRCT: $50.2M ADJUSTED EBITDA LOSS VS. $35M PROJECTED -- LEVI & KORSINSKY, LLP INVESTIGATES - Sahm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics CorporationPRCT - PR Newswire
Procept BioRobotics Balances Rapid Growth With Profit Push - TipRanks
PROCEPT BioRobotics Corp. Hits New 52-Week Low at $19.35 - Markets Mojo
PROCEPT BioRobotics Stock Hits Day Low of $19.35 Amid Price Pressure - Markets Mojo
PROCEPT BioRobotics Faces Weak Start with 30.5% Gap Down Amid Market Concerns - Markets Mojo
Mitsubishi UFJ Asset Management Co. Ltd. Sells 56,967 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Champlain Investment Partners LLC Grows Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Citigroup Inc. Purchases 45,979 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Investors Appear Satisfied With PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Prospects - 富途牛牛
PROCEPT BioRobotics (+14%): Cowen Conference Rebound After Earnings Sell-Off - Trefis
PROCEPT BioRobotics Corporation (PRCT) Investor Outlook: Unveiling the 23.55% Potential Upside in Healthcare Robotics - DirectorsTalk Interviews
William Blair Investment Management LLC Purchases 54,396 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Vanguard Group Inc. Sells 42,630 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Procept BioRobotics price target lowered to $30 from $47 at Truist - Yahoo Finance
PRCT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Procept BioRobotics at TD Cowen Conference: Strategic Growth Focus By Investing.com - Investing.com Nigeria
Procept BioRobotics at TD Cowen Conference: Strategic Growth Focus - Investing.com
PROCEPT BioRobotics (NASDAQ:PRCT) Stock Price Up 9.9%Here's Why - MarketBeat
JPMorgan Chase & Co. Cuts Stake in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Cowen Maintains Buy on PRCT PROCEPT BioRobotics Corporation Feb 2026 - Meyka
Procept Biorobotics Corp (PRCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.21%
0.24%
자본화:
|
볼륨(24시간):